We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.37B
AUM Growth
+$62.8M
Cap. Flow
-$112M
Cap. Flow %
-2.09%
Top 10 Hldgs %
20.35%
Holding
855
New
121
Increased
189
Reduced
310
Closed
120

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$45.7M
2
IDXX icon
Idexx Laboratories
IDXX
+$34.3M
3
CAH icon
Cardinal Health
CAH
+$30.2M
4
AMAT icon
Applied Materials
AMAT
+$24.5M
5
ELV icon
Elevance Health
ELV
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.73%
2 Financials 15.53%
3 Industrials 13.23%
4 Consumer Discretionary 12.83%
5 Technology 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENV
326
DELISTED
ENVESTNET, INC.
ENV
$684K 0.01%
13,917
-1,772
-11% -$83.3K
BRK.A icon
327
Berkshire Hathaway Class A
BRK.A
$1.08T
$678K 0.01%
3
SSO icon
328
ProShares Ultra S&P500
SSO
$8.53B
$675K 0.01%
84,112
+3,904
+5% +$29.8K
MEOH icon
329
Methanex
MEOH
$4.44B
$672K 0.01%
14,664
-35,757
-71% -$1.95M
LYB icon
330
LyondellBasell Industries
LYB
$20.2B
$671K 0.01%
8,457
-842,451
-99% -$73.1M
LNT icon
331
Alliant Energy
LNT
$17.8B
$667K 0.01%
20,098
+148
+0.7% +$4.58K
LDRH
332
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$655K 0.01%
19,986
+2,369
+13% +$77.8K
MHG
333
DELISTED
Marine Harvest ASA
MHG
$654K 0.01%
47,875
-6,800
-12% -$94.9K
FIVE icon
334
Five Below
FIVE
$13.6B
$642K 0.01%
+15,730
New +$637K
VIG icon
335
Vanguard Dividend Appreciation ETF
VIG
$113B
$638K 0.01%
7,867
+992
+14% +$78.4K
NTRS icon
336
Northern Trust
NTRS
$34.2B
$625K 0.01%
9,271
-3,580
-28% -$238K
ADBE icon
337
Adobe
ADBE
$116B
$622K 0.01%
+8,552
New +$599K
IHG icon
338
InterContinental Hotels
IHG
$24.1B
$622K 0.01%
+11,775
New +$601K
FITB
339
Fifth Third Bancorp
FITB
$49.8B
$619K 0.01%
30,363
-2,577
-8% -$51.2K
PFF icon
340
iShares Preferred and Income Securities ETF
PFF
$13.1B
$619K 0.01%
15,692
+385
+3% +$15.2K
ENH.PRA
341
DELISTED
ENDURANCE SPECIALTY HOLDINGS LTD PFD SER A
ENH.PRA
$610K 0.01%
23,200
+4,000
+21% +$105K
OGS icon
342
ONE Gas
OGS
$5.03B
$609K 0.01%
14,778
-1,054
-7% -$40.9K
RKUS
343
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$591K 0.01%
49,207
VEA icon
344
Vanguard FTSE Developed Markets ETF
VEA
$239B
$590K 0.01%
15,581
+2,457
+19% +$95.1K
SNAK
345
DELISTED
Inventure Foods, Inc.
SNAK
$588K 0.01%
46,192
+9,757
+27% +$127K
CHRD icon
346
Chord Energy
CHRD
$7.9B
$580K 0.01%
35,089
-641,512
-95% -$15.9M
EXAM
347
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$580K 0.01%
13,948
-4,840
-26% -$185K
PX
348
DELISTED
Praxair Inc
PX
$579K 0.01%
4,472
-879
-16% -$111K
WM icon
349
Waste Management
WM
$87.6B
$574K 0.01%
11,192
+778
+7% +$37.9K
SQM icon
350
Sociedad Química y Minera de Chile
SQM
$22.8B
$570K 0.01%
24,513
-14,857
-38% -$347K

Similar funds

Geneva Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Geneva Advisors held 855 positions worth $5.37B, up 1.2% from $5.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q4 2014 filing shows 121 new, 189 increased, 310 reduced and 120 closed positions. Its largest new stake was Idexx Laboratories: 488,650 shares worth $36.2M. The largest sale was LyondellBasell Industries, an estimated $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q4 2014 buy was Idexx Laboratories: 488,650 shares worth $36.2M.
  • Geneva Advisors added most to Alibaba in Q4 2014, an estimated $45.7M increase.
  • Geneva Advisors's biggest Q4 2014 reduction was LyondellBasell Industries, cutting an estimated $73.1M.
  • Geneva Advisors fully exited Community Health Systems in Q4 2014, selling an estimated $13M.
  • Geneva Advisors's ten largest holdings make up 20% of its $5.37B portfolio in Q4 2014.
  • Geneva Advisors opened 121 new positions and closed 120 in Q4 2014.
  • Geneva Advisors's portfolio value rose 1.2% quarter-over-quarter to $5.37B.

Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.